Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Current Assets (2016 - 2026)

Healthstream has reported Current Assets over the past 16 years, most recently at $119.7 million for Q4 2025.

  • Quarterly Current Assets fell 21.86% to $119.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $119.7 million through Dec 2025, down 21.86% year-over-year, with the annual reading at $119.7 million for FY2025, 21.86% down from the prior year.
  • Current Assets was $119.7 million for Q4 2025 at Healthstream, down from $147.6 million in the prior quarter.
  • Over five years, Current Assets peaked at $169.7 million in Q1 2025 and troughed at $95.3 million in Q2 2022.
  • The 5-year median for Current Assets is $122.4 million (2023), against an average of $126.6 million.
  • Year-over-year, Current Assets tumbled 43.62% in 2021 and then increased 23.79% in 2023.
  • A 5-year view of Current Assets shows it stood at $106.8 million in 2021, then rose by 7.05% to $114.4 million in 2022, then rose by 13.84% to $130.2 million in 2023, then rose by 17.6% to $153.1 million in 2024, then decreased by 21.86% to $119.7 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Current Assets are $119.7 million (Q4 2025), $147.6 million (Q3 2025), and $144.4 million (Q2 2025).